Markets:

Overview

News

Currencies

International

Treasuries

Medpace Holdings, Inc. - Common Stock (NQ:MEDP)

587.52 +4.36 (+0.75%)

Streaming Delayed Price Updated: 4:00 PM EDT, Sep 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Medpace Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Here’s How Much You Would Have Made Owning Medpace Holdings Stock In The Last 5 Years ↗

September 11, 2026

Medpace Holdings (NASDAQ:MEDP) has outperformed the market over the past 5 years by 15.31% on an annualized basis producing an average annual return of 26.82%. Currently, Medpace Holdings has a market...

Via Benzinga

2 Healthcare Stocks with Competitive Advantages and 1 We Question

September 09, 2026

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have not only reali...

Via StockStory

Innventure Announces Board Leadership Changes to Further Enhance Board Independence and Acceleration of CEO Transition

August 31, 2026

From Innventure, Inc.

Via GlobeNewswire

Medpace (MEDP): Buy, Sell, or Hold Post Q2 Earnings?

August 27, 2026

Medpace currently trades at $610.21 and has been a dream stock for shareholders. It’s returned 238% since August 2021, more than tripling the S&P 500’s 70.1%...

Via StockStory

Topics Stocks

Medpace Holdings (NASDAQ:MEDP) Jumps 17% After Q2 Earnings Beat and Raised Guidance ↗

July 22, 2026

Via Chartmill

Topics Earnings

If You Invested $1000 In Medpace Holdings Stock 10 Years Ago, You Would Have This Much Today ↗

August 26, 2026

Medpace Holdings (NASDAQ:MEDP) has outperformed the market over the past 10 years by 22.9% on an annualized basis producing an average annual return of 36.28%. Currently, Medpace Holdings has a market...

Via Benzinga

What Investors Should Know About Medpace CEO Troendle Selling $10 Million in Stock ↗

August 26, 2026

Troendle retains a $3.27 billion combined stake, representing 19% of the market cap, with the majority of holdings controlled through Medpace Investors, LLC.

Via The Motley Fool

Topics Regulatory Compliance

If You Invested $100 In Medpace Holdings Stock 5 Years Ago, You Would Have This Much Today ↗

August 14, 2026

Medpace Holdings (NASDAQ:MEDP) has outperformed the market over the past 5 years by 14.56% on an annualized basis producing an average annual return of 26.38%. Currently, Medpace Holdings has a market...

Via Benzinga

Drug Development Inputs & Services Stocks Q2 Recap: Benchmarking Medpace (NASDAQ:MEDP)

August 13, 2026

As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug development inputs & services ind...

Via StockStory

2 Mid-Cap Stocks Worth Your Attention and 1 We Question

August 13, 2026

Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to beco...

Via StockStory

3 High-Flying Stocks with Solid Fundamentals

August 03, 2026

Expensive stocks often command premium valuations because the market thinks their business models are exceptional. However, the downside is that high expecta...

Via StockStory

3 Cash-Heavy Stocks on Our Watchlist

July 31, 2026

Companies with more cash than debt often have stronger financial flexibility, making them attractive in uncertain markets. With interest payments less of a w...

Via StockStory

2 Momentum Stocks with Exciting Potential and 1 We Question

July 24, 2026

Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such a...

Via StockStory

Why Is Medpace (MEDP) Stock Soaring Today

July 23, 2026

What Happened? Shares of clinical research company Medpace Holdings (NASDAQ:MEDP) jumped 14.4% in the afternoon session after the company reported second-qua...

Via StockStory

Medpace Q2 Earnings Call Highlights ↗

July 23, 2026

Medpace (NASDAQ:MEDP) reported double-digit growth in second-quarter revenue and earnings, while management described the business environment as strong and said lower cancellations helped drive record...

Via MarketBeat

Topics Earnings

The market is filled with gapping stocks in Thursday's session. ↗

July 23, 2026

Via Chartmill

Which stocks are moving before the opening bell on Thursday? ↗

July 23, 2026

Via Chartmill

What's going on in today's after hours session ↗

July 22, 2026

Via Chartmill

Medpace (NASDAQ:MEDP) Exceeds Q2 CY2026 Expectations, Stock Jumps 18.6%

July 22, 2026

Clinical research company Medpace Holdings (NASDAQ:MEDP) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 17.2% year on year ...

Via StockStory

Medpace Holdings, Inc. Reports Second Quarter 2026 Results

July 22, 2026

From Medpace Holdings, Inc.

Via Business Wire

What To Expect From Medpace’s (MEDP) Q2 Earnings

July 20, 2026

Clinical research company Medpace Holdings (NASDAQ:MEDP) will be reporting earnings this Wednesday after market hours. Here’s what investors should know. Med...

Via StockStory

2 Healthcare Stocks to Consider Right Now and 1 We Brush Off

June 25, 2026

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advanceme...

Via StockStory

3 Market-Beating Stocks to Target This Week

June 23, 2026

The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital, and those that can maintain this trifecta y...

Via StockStory

Medpace Holdings, Inc. to Report Second Quarter 2026 Financial Results on July 22, 2026

June 16, 2026

From Medpace Holdings, Inc.

Via Business Wire

1 Profitable Stock to Consider Right Now and 2 We Brush Off

June 15, 2026

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi...

Via StockStory

MEDP DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Medpace (MEDP) Investors of Securities Class Action Deadline on June 8, 2026

June 08, 2026

From Faruqi & Faruqi, LLP

Via Business Wire

CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Highlights Class Action Against Medpace Holdings (MEDP) and Upcoming Lead Plaintiff Deadline of June 8, 2026

June 08, 2026

From Faruqi & Faruqi, LLP

Via Business Wire

MEDP Deadline: Rosen Law Firm Urges Medpace Holdings, Inc. (NASDAQ: MEDP) Stockholders to Contact the Firm for Information About Their Rights

June 05, 2026

From The Rosen Law Firm, P.A.

Via Business Wire

MEDPACE DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Medpace Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 8 Deadline in Securities Class Action - MEDP

June 04, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

MEDPACE HOLDINGS DEADLINE TOMORROW JUNE 5th: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Medpace Holdings, Inc. and Encourages Investors to Contact the Firm Before June 5th

June 04, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.